Chatrapatiy Impex Pharma India Private Limited - Company Profile

It is a paper private limited company based in Ramtek, Maharashtra, India, established in 2024.
2024 Ramtek, Maharashtra, India Active
Last Updated:
Access Report
About Chatrapatiy Impex Pharma India Private Limited

Chatrapatiy Impex Pharma India Private Limited, a active private limited company, was established on 01 January 2024 in Ramtek, Maharashtra, India. Engaging in paper & paper products within the paper sector, it holds CIN: U21000MH2024PTC416467. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹10.00 K .

Its leadership includes Sumeet Kiran Choudhary (Director), Amit Kiran Choudhary (Director). It is based at Shop 1 & 2.Gf, Ward No 01, Mauli Rd, Mansar, Ramtek, Ramtek, Maharashtra, 441401.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21000MH2024PTC416467

  • Registration Number

    416467

  • Incorporation Date

    01 January 2024

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹10.00 K

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 10.00 K
  • Company Age 2 Year, 1 Month
Company report

Chatrapatiy Impex Pharma India Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Chatrapatiy Impex Pharma India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Chatrapatiy Impex Pharma India Private Limited?
Current Directors
Name Designation Appointment Date Status
Sumeet Kiran Choudhary Director 01 Jan 2024 Current
Amit Kiran Choudhary Director 01 Jan 2024 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Chatrapatiy Impex Pharma India.

Enhance accessibility to Chatrapatiy Impex Pharma India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Chatrapatiy Impex Pharma India revenue growth over time
Chatrapatiy Impex Pharma India profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Chatrapatiy Impex Pharma India?

Unlock access to Chatrapatiy Impex Pharma India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Chatrapatiy Impex Pharma India?

Unlock and access historical data on people associated with Chatrapatiy Impex Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Chatrapatiy Impex Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chatrapatiy Impex Pharma India's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Chatrapatiy Impex Pharma India
Recent Activity within the Organization
  • Director Appointment

    The activity Sumeet Kiran Choudhary was appointed as a Director was appointed as a Director on 01 Jan 2024 & has been associated with this company since 2 years 1 month . was completed.

  • Director Appointment

    Progress on Amit Kiran Choudhary was appointed as a Director was appointed as a Director on 01 Jan 2024 & has been associated with this company since 2 years 1 month . was documented.

  • Company Incorporation

    The activity Chatrapatiy Impex Pharma India Private Limited was registered on 01 Jan 2024 with Roc Mumbai & aged 2 years 1 month as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Chatrapatiy Impex Pharma India Private Limited?

The CIN of Chatrapatiy Impex Pharma India Private Limited is U21000MH2024PTC416467.

Where is Chatrapatiy Impex Pharma India Private Limited headquartered?

Chatrapatiy Impex Pharma India Private Limited is headquartered at Shop 1 & 2.Gf, Ward No 01, Mauli Rd, Mansar, Ramtek, Ramtek, Maharashtra, 441401.

When was Chatrapatiy Impex Pharma India Private Limited incorporated?

Chatrapatiy Impex Pharma India Private Limited was incorporated on 01 January 2024.

Who are the current directors of Chatrapatiy Impex Pharma India Private Limited?

The current directors of Chatrapatiy Impex Pharma India Private Limited are

What is the primary industry of Chatrapatiy Impex Pharma India Private Limited?

The primary industry of Chatrapatiy Impex Pharma India Private Limited is Paper.

Is Chatrapatiy Impex Pharma India Private Limited a listed company?

Chatrapatiy Impex Pharma India Private Limited is unlisted.

What is the capital structure of Chatrapatiy Impex Pharma India Private Limited?

The authorized capital of Chatrapatiy Impex Pharma India Private Limited is ₹0.50 M, and the paid-up capital is ₹10.00 K .

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available